FHIT Suppresses Prostaglandin E_2 in the Carcinogenic Activity by Inflammation in Colorectal Cancer.

FHIT 通过结直肠癌炎症抑制前列腺素 E_2 的致癌活性。

基本信息

  • 批准号:
    15390379
  • 负责人:
  • 金额:
    $ 9.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

The FHIT gene is considered to be susceptible to environmental carcinogens, such as tobacco and alcohols. The inflammation in the cmicrocircumstances were defined by arachidonic cascade which is mediated through cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) may influence the malignant phenotype of colorectal cancer (CRC) by acting as mediators in carcinogen affected epithelial tissues. In the present study, immunohistochemical analysis of 62 CRCs showed that a subset of CRC cases with COX-2 overexpression but no FHIT expression exhibited more advanced clinicopathological features (depth of tumor invasion, p < 0.007 ; Dukes stage, p < 0.007), compared to cases with undetectable COX-2 but positive FHIT expression. In vitro experiments using induced FHIT expressing cells showed a diminished COX-2 expression by western blotting compared with control cells. Moreover, after stimulation by COX-2 inducers (lipopolysaccharide, phorbol 12-myristate 13-acetate or interleukin 1 beta), PGE2 … More production and cell proliferation were repressed (0.75-fold and 0.87-fold) in FHIT expressing cells compared to control cells, as determined by ELISA and MTT assays, respectively. On the other hand, we established FHIT siRNA clones and repressed FHIT expression in colorectal cancer cell line, CCK81. As a result, PGE2 production by ELISA and the cellular proliferation by MTT assay was diminished in the FHIT inhibited cell by RNAi comparing with the control FHIT. In conclusion, loss of FHIT expression with overexpression of COX-2 in CRC may predict a higher malignant potential. Conversely, FHIT protein induction repressed cell proliferation by inhibiting prostaglandin E2 production in colorectal cancer.Moreover, the current comprehensive gene analysis after adenoviral-FHIT (Ad-FHIT) treatment is therefore considered to shed some light on the following two points. One is to clarify the mechanism of apoptotic activity by Ad-FHIT and the other is to identify the candidate cancer associated targets affected by Ad-FHIT treatment. Those molecules may consider to be a fine target under the inflammation mediated carcinogenic activity in CRC cases. Less
FHIT基因被认为易受环境致癌物的影响,如烟草和酒精。微环境中的炎症反应是由环氧合酶-2(考克斯-2)介导的花生四烯酸级联反应引起的,前列腺素E2(PGE 2)可能通过在致癌物影响的上皮组织中起介导作用而影响结直肠癌(CRC)的恶性表型。在本研究中,62例CRC的免疫组化分析显示,与检测不到考克斯-2但FHIT表达阳性的病例相比,考克斯-2过表达但FHIT表达阴性的CRC病例亚组表现出更晚期的临床病理特征(肿瘤浸润深度,p <0.007 ; Dukes分期,p < 0.007)。使用诱导的FHIT表达细胞的体外实验显示,与对照细胞相比,通过蛋白质印迹法,考克斯-2表达减少。此外,在用考克斯-2诱导剂(脂多糖、佛波醇12-肉豆蔻酸酯13-乙酸酯或白细胞介素1 β)刺激后, ...更多信息 与对照细胞相比,FHIT表达细胞中FHIT的产生和细胞增殖被抑制(0.75倍和0.87倍),这分别通过ELISA和MTT测定来确定。另一方面,我们建立了FHIT siRNA克隆,并在大肠癌细胞系CCK 81中抑制FHIT表达。结果表明,与对照组相比,RNAi抑制FHIT细胞PGE 2的产生和MTT法细胞增殖均明显降低。总之,FHIT表达缺失伴考克斯-2过表达的结直肠癌可能预示着更高的恶性潜能。相反,FHIT蛋白的诱导通过抑制前列腺素E2的产生而抑制结直肠癌细胞的增殖。此外,目前对腺病毒-FHIT(Ad-FHIT)治疗后的全面基因分析因此被认为在以下两点上提供了一些线索。一是阐明Ad-FHIT的凋亡作用机制,二是鉴定Ad-FHIT治疗影响的候选肿瘤相关靶点。这些分子可能被认为是CRC病例中炎症介导的致癌活性的良好靶点。少

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
N-cardherin is regulated by activin a and associated with tumor aggressiveness in esophageal carcinoma.
N-cardherin 受激活素 a 调节,与食管癌的肿瘤侵袭性相关。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    山田祐一郎;松本慎一ら;Jiang YL;Yoshinaga K
  • 通讯作者:
    Yoshinaga K
Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX
Coexpression of MMP-7 and EGF receptor in colorectal cancer, an EGF receptor tyrosine kinase inhibitor is effective against MMP-7 expressing cancer cells.
MMP-7 和 EGF 受体在结直肠癌中共表达,EGF 受体酪氨酸激酶抑制剂可有效对抗表达 MMP-7 的癌细胞。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nagata H;Matsumoto S;et al.;Ohno Y;Hara I;松本慎一;Mimori K
  • 通讯作者:
    Mimori K
乳癌診断のコツと落とし穴
乳腺癌诊断的技巧和陷阱
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nagahara H;Mimori K;Mimori K;Mimori K;三森功士
  • 通讯作者:
    三森功士
Ishii H, Mimori K.et al.: "Effect of exogeneous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX."BBRC. 2004. (2004)
Ishii H、Mimori K.等人:“外源 E2F-1 对常见染色体脆弱位点基因 FHIT 和 WWOX 表达的影响。”BBRC。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KOSHI Mimori其他文献

KOSHI Mimori的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KOSHI Mimori', 18)}}的其他基金

Clarification of the mechanism giving rise to metastasis by the analysis of gene expression in bone marrow and peripheral blood in cancer patients
通过分析癌症患者骨髓和外周血中的基因表达来阐明引起转移的机制
  • 批准号:
    19390336
  • 财政年份:
    2007
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Multi-layered decoding and therapeutic co-option of the metastatic checkpoint in human colorectal cancer
人类结直肠癌转移检查点的多层解码和治疗选择
  • 批准号:
    23K27677
  • 财政年份:
    2024
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The development of targeterd therapies for Intra-mitochondrial calcium ion dinamics in colorectal cancer stem cells
结直肠癌干细胞线粒体内钙离子动态靶向疗法的开发
  • 批准号:
    23K06654
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of cell differentiation in colorectal cancer progression
细胞分化在结直肠癌进展中的作用
  • 批准号:
    23K06661
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Netrin-1 receptor "deleted in colorectal cancer" (DCC) signalosome in axonal development
Netrin-1 受体“在结直肠癌中缺失”(DCC) 轴突发育中的信号体
  • 批准号:
    488616
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Operating Grants
Investigating the Role of Drug Tolerant Persisters in Driving Colorectal Cancer Metastasis.
研究耐药性持续存在在驱动结直肠癌转移中的作用。
  • 批准号:
    491461
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Fellowship Programs
Elucidation of molecular mechanisms of interaction between colorectal cancer cells and stromal cells in tumor budding area
阐明结直肠癌细胞与肿瘤出芽区基质细胞相互作用的分子机制
  • 批准号:
    23K15489
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
New strategy for preventing colorectal cancer by targeting polyamines, which are thought to be carcinogens
通过针对被认为是致癌物质的多胺来预防结直肠癌的新策略
  • 批准号:
    23K17454
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
CanSense-CRC: early detection of colorectal cancer
CanSense-CRC:结直肠癌的早期检测
  • 批准号:
    10068039
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Collaborative R&D
Exercise prehabilitation in colorectal cancer: establishing mechanisms of adaptation to advance optimisation and stratification.
结直肠癌的运动预康复:建立适应机制以推进优化和分层。
  • 批准号:
    MR/X005240/1
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Research Grant
The regulation of hybrid-EMT and metastasis in colorectal cancer
混合EMT与结直肠癌转移的调控
  • 批准号:
    MR/X008762/1
  • 财政年份:
    2023
  • 资助金额:
    $ 9.41万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了